AstraZeneca's baxdrostat demonstrated significant blood pressure reduction in a late-stage trial for treatment-resistant ...

The latest investor updates on stocks that are trending on Monday.

AstraZeneca said on Monday its experimental drug baxdrostat significantly lowered blood pressure in a late-stage trial of ...

A PERSON has died from plague just 24-hours after they showed up at hospital with symptoms, health officals have said. The victim was rushed to Flagstaff Medical Center in Arizona, US, showing ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

AstraZeneca’s $1.3 billion bet on CinCor Pharma and its mid-phase hypertension drug baxdrostat seems to have paid off based ...

Baxdrostat is one of several drugs AstraZeneca is developing in cardiovascular, renal, and metabolic disease areas. The ...

(Alliance News) - AstraZeneca PLC on Monday said a test of its baxdrostat drug showed a "meaningful reduction" in hypertension. The Cambridge, England-based pharmaceutical and biotechnology firm ...

AstraZeneca 's experimental drug baxdrostat has been successful in lowering high blood pressure in a late-stage study of ...

One, it makes sense for AstraZeneca Plc to move its main listing to New York, and two, such a terrible symbolic blow for the ...

Imugene is tapping the market for up to $35 million, while Clever Culture Systems and Compumedics are soaring on positive ...

Danaher Corporation (NYSE:DHR) is a leading global life sciences and diagnostics innovation company. With a focus on science ...